Annonce

Log ud Log ind
Log ud Log ind
Formue

Aquaporin 2,9 mio. kr. i salg 1H, årsforventning 15-20 mio. kr.

Morten W. Langer

søndag 05. september 2021 kl. 11:35

Aquaporin: Denne kapitalforhøjelse er den sidste

Fra Aquaporin:

Highlights

  • Successful capital raise of DKK 250 million in gross proceeds in connection with initial public offering secured funds to execute on the commercialization strategy laid out in the Prospectus published 14 June 2021.
  • Revenue grew 176% to DKK 2.9 million in the first six months of 2021 (1.0 million); Drinking Water (60%) and Industrial Water (37%) were the primary revenue drivers.
  • Drinking water revenue growth was driven by sales in both point-of-use (“PoU”) systems (purifiers, systems) and non-PoU (membranes, flatsheets).
  • Solid traction in Industrial Water with 8 new pilot projects launched in the first six months of 2021 (currently 18 ongoing). Aquaporin was selected to collaborate with the “Fashion for Good” program in South Asia to develop innovative treatment of wastewater in the textile industry.
  • Food & Beverage successfully achieved lab-scale and prototype proof of concept in H1 2021 and has commenced the next phase of development with partners and customers to scale up solutions.
  • EBITDA amount to a loss of DKK 37.7 million, compared to a loss of DKK 41.7 million in 2020.
  • Cash & cash equivalents at the end of the period amounted to DKK 219.9 million (1.2 million).
  • Chief Commercial Officer and Deputy CEO Matt Boczkowski and Chief Operating Officer Joerg Hess became registered members of the Executive Board.
  • Full-year financial outlook maintained based on ongoing positive dialogue with potential customers and positive development in the order book, underlined by large order of 2,500 point-of-use purifiers secured immediately after end of first half of 2021.

 

Outlook for full year 2021

RevenueDKK 15-20 million
EBITDA (before special items)DKK (70-80) million
EBIT (before special items)DKK (90-100) million

 

Comment by Peter Holme Jensen, CEO:

“We are excited to announce our first interim report as a listed company. As part of the IPO, we raised gross proceeds of DKK 250 million. This enables us to focus on building a strong commercial organization, continue our efforts in R&D and do our part in creating a more sustainable future. The first six months of 2021 have been satisfactory from a business perspective where we have continued development and testing of solutions in all key markets. We strengthened the organization in all areas, not least with the addition of Matt Boczkowski as Deputy CEO and CCO – Matt’s experience with sales, marketing and business development from global leaders in the industry is key to building a best-in-class commercial foundation and promote a customer-centric commercial culture at Aquaporin. We move into the second half of 2021 with a clear roadmap to grow Aquaporin’s financial footprint and execute on the strategy presented in connection with the IPO.”

 

Få dagens vigtigste
økonominyheder hver dag kl. 12

Bliv opdateret på aktiemarkedets bevægelser, skarpe indsigter
og nyeste tendenser fra Økonomisk Ugebrev – helt gratis.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev.  Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik. Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

Udløber snart
Finance Manager
Region Nordjylland
SUN-AIR i Billund søger en kreditorbogholder
Region Syddanmark
Finansiel controller med stærk forretningsforståelse
Region Sjælland
Financial Controller til HMF Group A/S
Region Midt
Udløber snart
Dansk Sygeplejeråd søger en regnskabskonsulent med digitalt mindset og med erfaring i regnskabsprocessen fra A-Z (barselsvikariat)
Region Hovedstaden

Mere fra ØU Formue

Log ind

Har du ikke allerede en bruger? Opret dig her.

Påskegave

Få to GRATIS analyser af Novo Nordisk & Zealand Pharma 

*Tilbuddet gælder ikke, hvis man har været abonnent indenfor de seneste 6 måneder

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank